Citius Oncology, Inc. (CTOR) stock news · $105.2M cap
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
This CTOR news page leads with what Citius Oncology, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for CTOR yet. We will not pad this page with generic market recap.
Latest reported CTOR revenue for 2026-06-30 was $1.5M. Net income was -$8.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTOR stock page; for the tape open the quote page.
CTOR stock news FAQ
What are CTOR's latest revenue and net income?
Latest cached Citius Oncology, Inc. (CTOR) revenue for Jun 30, 2026 was $1.5M. Net income was -$8.9M. Statements: https://lician.com/financials/ctor
How did CTOR revenue change from the prior cached period?
Cached Citius Oncology, Inc. (CTOR) revenue was down 10.4% from $1.7M (Mar 31, 2026) to $1.5M (Jun 30, 2026). Statements: https://lician.com/financials/ctor
What is CTOR's market cap?
Citius Oncology, Inc. (CTOR) market cap is $105.2M on the latest cached fundamentals snapshot.
What kind of company is CTOR?
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Where is CTOR stock news listed?
Cached stock news for Citius Oncology, Inc. (CTOR) is listed at https://lician.com/news/ctor. Filings: https://lician.com/sec/ctor
Not investment advice.